Dukes B ´ëÀå¾ÏÁ¾¿¡¼ ¸²ÇÁÀüÀÌÀÇ ÀÓ»óÀû ÀÇÀÇ
Clinical Significance of Lymph Node Micrometastasis in Patients with Dukes¢¥ B Colorectal Cancer
ÀÌÈ¿¿ø, Àå¿ë¼®,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÈ¿¿ø ( Lee Hyo-Won )
¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
Àå¿ë¼® ( Jang Yong-Seog )
¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
KMID : 0356720040200010057
Abstract
Purpose: This study aimed to provide immunohistochemical evidence of micrometastasis in patients with node-negative Dukes¢¥ B colorectal cancer and to evaluate the clinical implications, including prognostic significance, of lymphatic metastasis.
Methods: A retrospective study of 90 patients who underwent a curative operation due to colorectal neoplasms from 1996 to 2001 was performed. Two consecutive sections of lymph nodes were prepared: one for ordinary hematoxylin-eosin staining, and the other for immunohistochemistry with pancytokeratine antibody. All clinical factors, including survival rate, were compared between patients with and without lymph-node metastasis. The mean follow- up period was 36.1 months.
Results: Micrometastasis was confirmed in 115 nodes (7.9%) from 32 patients (35.6%). No correlations were observed between micrometastases and prognostic factors, including survival rate, except for lymphatic invasion and postoperative TNM staging. Twenty-six of the 32 (81.3%) patients with micrometastases belonged to stage T3N0M0 (P£¼0.003).
Conclusions: The immunohistochemical assay may be a useful way to identify micrometastasis in patients with Dukes¢¥ B colorectal neoplasms, but we were not able to demonstrate the prognostic significance of micrometastasis. J Korean Soc Coloproctol 2004;20:57-63
Å°¿öµå
°áÀåÁ÷ÀåÁ¾¾ç;Dukes¢¥ B;¸²ÇÁÀüÀÌ;»ýÁ¸À²;¸é¿ªÁ¶Á÷ÈÇÐ
Colorectal neoplasms;Dukes¢¥ B;Lymphatic metastasis;Survival rate;Immunohistochemistry
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸